Cancer Biomarkers Market by Biomarker Type (Genetic Biomarkers, Protein Biomarkers, and Other Biomarkers); by Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer, and Other Cancer Types); by Profiling Technology (Imaging technologies, Omic Technologies (Proteomics, Genomics, and Other Omic Technologies), Cytogenetics-Based Tests, and Immunoassays); and for Application (Drug discovery and Development, Personalized medicine, Diagnostics, and Other Applications): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2024

Global cancer biomarkers market expected to generate revenue of around USD 26,000 million by end of 2024, growing at a CAGR of around 13% between 2018 and 2024. Cancer biomarkers are perceptible substances, that are used as an indicator of the biological status of the tumor and hence they are used to analyze the prognostic and diagnostic stages of cancer.

01-Oct-2018 | Number of pages: 140 | Report Code: ZMR-2641 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the cancer biomarkers market on a global and regional level. The study provides historic data of 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the cancer biomarkers market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer biomarkers market on a global level.

In order to give the users of this report a comprehensive view of the cancer biomarkers market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein biomarker type segment, cancer type segment, , and profiling technology segment are benchmarked based on their market size, growth rate, and general attractiveness.

Global Cancer Biomarkers Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new cancer type launch, agreements, partnerships, collaborations & joint ventures, research & development, cancer type, and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, product portfolio of various companies according to region.

The study provides a decisive view of the cancer biomarkers market by segmenting the market based on biomarker type segment, cancer type, and profiling technology, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on biomarker type the global cancer biomarkers market is segmented as genetic biomarkers, protein biomarkers, and other biomarkers. Based on cancer type, the market is segmented as breast cancer, colorectal cancer, lung cancer, prostate cancer, blood cancer, melanoma, ovarian cancer, liver cancer, stomach cancer, and other cancer types. By profiling technology, the cancer market is further segmented as imaging technologies, omic technologies, cytogenetics-based tests, and immunoassays. The omic technologies segment is further segmented as genomics, proteomics, and other omic technologies. Based on applications, the cancer biomarkers market segmented as drug discovery and development, personalized medicine, diagnostics, and other applications. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S., Rest of North America, U.K., Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa and Rest of Middle East and Africa. 

The report also includes detailed profiles of end players such as Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Agilent Technologies, QIAGEN, Illumina, Inc., QIAGEN, Sino Biological Inc., Merck & Co., Inc., Novartis AG, Hologic, Inc., bioMérieux SA, Genomic Health, Inc.

This report segments the global cancer biomarkers market as follows:

Global Cancer Biomarkers Market: Biomarker Type Segment Analysis

  • Genetic Biomarkers 
  • Protein Biomarkers 
  • Other Cancer Biomarkers

Global Cancer Biomarkers Market: Cancer Type Segment Analysis

  • Breast Cancer 
  • Lung Cancer 
  • Prostate Cancer 
  • Colorectal Cancer 
  • Blood Cancer
  • Melanoma 
  • Ovarian Cancer
  • Liver Cancer
  • Stomach Cancer
  • Other Cancer Types 

Global Cancer Biomarkers Market: Profiling Technology Segment Analysis

  • Imaging technologies
  • Omic Technologies
    • Proteomics
    • Genomics
    • Other Omic technologies
  • Cytogenetics-Based Tests
  • Immunoassays

Global Cancer Biomarkers Market: Applications  Segment Analysis

  • Drug discovery and Development
  • Personalized medicine
  • Diagnostics
  • Others

Global Cancer Biomarkers Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Human Milk Oligosaccharides (HMO) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3837 | Report Format:

Global Human Milk Oligosaccharides (HMO) Market: Overview Human milk oligosaccharides (HMO) is present in human milk in the form of a complex bioactive sugar molecule. HMOs are growth substrates for certain useful bacteria. Extracting or synthesizing HMO in the formula is quite difficult as they...Read More

Nutritional Analysis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3832 | Report Format:

Global Nutritional Analysis Market: Overview Nutritional analysis is referred to as the general analysis of the presence of nutritional content within the food and edible products. It provides analysis of food quality and safety and is used extensively in menu labeling and nutritional fact label...Read More

Animal Genetics Market by Product (Live Animals (Porcine, Poultry, Canine, Bovine, and Others) and Genetic Material (Embryo and Semen)) and by Service (Genetic Disease Tests, Genetic Trait Tests, DNA Typing, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3718 | Report Format:

The report covers a forecast and an analysis of the animal genetics market on a global and regional level. The study provides historical data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the animal ge...Read More

Primary Cells Market by Origin (Hematopoietic Cells, Renal Cells, Skin Cells, Lung Cells, Gastrointestinal Cells, Heart, Liver Cells, Skeletal and Muscle Cells, and Other Primary Cells), by Type (Human Primary Cells and Animal Primary Cells), and by End-User (Life Science Research Companies and Research Institutes): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Jan-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3689 | Report Format:

The report covers a forecast and an analysis of the primary cells market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the primary cells mark...Read More

Viral Vectors and Plasmid DNA Manufacturing Market by Product Type (Viral Vectors (Retrovirus, Lentiviruses, Adenoviruses, Adeno-Associated Viruses, and Others) and Plasmid (DNA Conjugative Plasmids, and Non-Conjugative Plasmids)), by Application (Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, and Others), and by End-User (Biotechnology Companies, Research Institutes, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2026

Dec-2018 | Price : $ 4899.00 | Pages: 120 | Report Code: ZMR-3664 | Report Format:

The report covers a forecast and an analysis of the viral vectors and plasmid DNA manufacturing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2026 based on revenue (USD Million). The study includes drivers and restrai...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.